KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Total Debt (2017 - 2025)

Historic Total Debt for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to $2.6 billion.

  • Amneal Pharmaceuticals' Total Debt rose 749.29% to $2.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 billion, marking a year-over-year increase of 749.29%. This contributed to the annual value of $2.4 billion for FY2024, which is 697.86% down from last year.
  • Amneal Pharmaceuticals' Total Debt amounted to $2.6 billion in Q3 2025, which was up 749.29% from $2.4 billion recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Total Debt ranged from a high of $2.8 billion in Q1 2021 and a low of $2.4 billion during Q4 2024
  • Over the past 5 years, Amneal Pharmaceuticals' median Total Debt value was $2.7 billion (recorded in 2022), while the average stood at $2.6 billion.
  • Its Total Debt has fluctuated over the past 5 years, first tumbled by 1022.13% in 2021, then skyrocketed by 749.29% in 2025.
  • Quarter analysis of 5 years shows Amneal Pharmaceuticals' Total Debt stood at $2.7 billion in 2021, then dropped by 2.78% to $2.7 billion in 2022, then decreased by 3.28% to $2.6 billion in 2023, then decreased by 6.98% to $2.4 billion in 2024, then rose by 7.87% to $2.6 billion in 2025.
  • Its Total Debt stands at $2.6 billion for Q3 2025, versus $2.4 billion for Q2 2025 and $2.4 billion for Q1 2025.